Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms

Journal of Biological Chemistry

Volumn 287, Issue 39, 2012, Pages 32512-32524

  Wang, Chi Yun ^a   Chen, Chia Ling ^a   Tseng, Yau Lin ^a   Fang, Yi Ting ^a   Lin, Yee Shin ^a   Su, Wu Chou ^a   Chen, Chien Chin ^a   Chang, Kung Chao ^a   Wang, Yi Ching ^a   Lin, Chiou Feng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

A549 CELLS; ANNEXINS; CELL CYCLE; CELL-CYCLE ARREST; IN-VITRO; IN-VIVO; MOLECULAR MECHANISM; NON SMALL CELL LUNG CANCER; OVER-EXPRESSION; TUMOR GROWTH;

ANTIBIOTICS; BIOLOGICAL ORGANS; CELL PROLIFERATION; CYTOLOGY; DIAGNOSIS; TRANSCRIPTION;

CELLS;

LIPOCORTIN 2; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL LINE; CELL PROLIFERATION; CELL STRAIN A549; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INACTIVATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANNEXIN A2; CARCINOMA, NON-SMALL-CELL LUNG; G2 PHASE CELL CYCLE CHECKPOINTS; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MAP KINASE KINASE 4; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866527752     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.351957     Document Type: Article

References (89)

1. Hajjar, K. A., and Krishnan, S. (1999) Annexin II. A mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med. 9, 128-138 (Pubitemid 30001891)
2. Johnsson, N., Marriott, G., and Weber, K. (1988) p36, the major cytoplasmic substrate of Src tyrosine protein kinase, binds to its p11 regulatory subunit via a short amino-terminal amphiphatic helix. EMBO J. 7, 2435-2442
3. 2+handling in the heart. Cardiovasc. Res. 65, 793-802
4. Hajjar, K. A., Jacovina, A. T., and Chacko, J. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 269, 21191-21197
5. Kassam, G., Manro, A., Braat, C. E., Louie, P., Fitzpatrick, S. L., and Waisman, D. M. (1997) Characterization of the heparin binding properties of annexin II tetramer. J. Biol. Chem. 272, 15093-15100 (Pubitemid 27255522)
6. Gerke, V., and Moss, S. E. (1997) Annexins and membrane dynamics. Biochim. Biophys. Acta 1357, 129-154 (Pubitemid 27278039)
7. Waisman, D. M. (1995) Annexin II tetramer. Structure and function. Mol. Cell Biochem. 149, 301-322
8. Raynal, P., and Pollard, H. B. (1994) Annexins. The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta 1197, 63-93
9. Nygaard, S. J., Haugland, H. K., Kristoffersen, E. K., Lund-Johansen, M., Laerum, O. D., and Tysnes, O. B. (1998) Expression of annexin II in glioma cell lines and in brain tumor biopsies. J. Neurooncol. 38, 11-18 (Pubitemid 28107888)
10. Roseman, B. J., Bollen, A., Hsu, J., Lamborn, K., and Israel, M. A. (1994) Annexin II marks astrocytic brain tumors of high histologic grade. Oncol. Res. 6, 561-567
11. Menell, J. S., Cesarman, G. M., Jacovina, A. T., McLaughlin, M. A., Lev, E. A., and Hajjar, K. A. (1999) Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 340, 994-1004 (Pubitemid 29157631)
12. Mai, J., Finley, R. L., Jr., Waisman, D. M., and Sloane, B. F. (2000) Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275, 12806-12812 (Pubitemid 30241435)
13. Emoto, K., Sawada, H., Yamada, Y., Fujimoto, H., Takahama, Y., Ueno, M., Takayama, T., Uchida, H., Kamada, K., Naito, A., Hirao, S., and Nakajima, Y. (2001) Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res. 21, 1339-1345
14. Emoto, K., Yamada, Y., Sawada, H., Fujimoto, H., Ueno, M., Takayama, T., Kamada, K., Naito, A., Hirao, S., and Nakajima, Y. (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression.Aprognostic marker in colorectal carcinoma. Cancer 92, 1419-1426 (Pubitemid 32947825)
15. Esposito, I., Penzel, R., Chaib-Harrireche, M., Barcena, U., Bergmann, F., Riedl, S., Kayed, H., Giese, N., Kleeff, J., Friess, H., and Schirmacher, P. (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J. Pathol. 208, 673-685
16. Sharma, M. R., Koltowski, L., Ownbey, R. T., Tuszynski, G. P., and Sharma, M. C. (2006) Angiogenesis-associated protein annexin II in breast cancer. Selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp. Mol. Pathol. 81, 146-156 (Pubitemid 44715786)
17. Sharma, M. R., Rothman, V., Tuszynski, G. P., and Sharma, M. C. (2006) Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis lung carcinoma tumor growth via blocking of plasminogen activation. Possible biochemical mechanism of angiostatin's action. Exp. Mol. Pathol. 81, 136-145 (Pubitemid 44715785)
18. Mohammad, H. S., Kurokohchi, K., Yoneyama, H., Tokuda, M., Morishita, A., Jian, G., Shi, L., Murota, M., Tani, J., Kato, K., Miyoshi, H., Deguchi, A., Himoto, T., Usuki, H., Wakabayashi, H., Izuishi, K., Suzuki, Y., Iwama, H., Deguchi, K., Uchida, N., Sabet, E. A., Arafa, U. A., Hassan, A. T., El-Sayed, A. A., and Masaki, T. (2008) Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int. J. Oncol. 33, 1157-1163
19. Bao, H., Jiang, M., Zhu, M., Sheng, F., Ruan, J., and Ruan, C. (2009) Overexpression of Annexin II affects the proliferation, apoptosis, invasion, and production of proangiogenic factors in multiple myeloma. Int. J. Hematol. 90, 177-185
20. Liu, J., Rothermund, C. A., Ayala-Sanmartin, J., and Vishwanatha, J. K. (2003) Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of Ser-11 and -25 to Glu prevents nucleo-cytoplasmic shuttling of annexin II. BMC Biochem. 4, 10-26
21. Zhang, X., Zhi, H. Y., Zhang, J., Wang, X. Q., Zhou, C. N., Wu, M., Sun, Y. T., and Liu, Z. H. (2003) [Expression of annexin II in human esophageal squamous cell carcinoma]. Zhonghua Zhong Liu Za Zhi 25, 353-355
22. Gillette, J. M., Chan, D. C., and Nielsen-Preiss, S. M. (2004) Annexin 2 expression is reduced in human osteosarcoma metastases. J. Cell Biochem. 92, 820-832 (Pubitemid 44264271)
23. Rodrigo, J. P., Lequerica-Fernández, P., Rosado, P., Allonca, E., Garcia-Pedrero, J. M., and de Vicente, J. C. (2011) Clinical significance of annexin A2 down-regulation in oral squamous cell carcinoma. Head Neck 33, 1708-1714
24. Paciucci, R., Torà, M., Díaz, V. M., and Real, F. X. (1998) The plasminogen activator system in pancreas cancer. Role of t-PA in the invasive potential in vitro. Oncogene 16, 625-633 (Pubitemid 28062342)
25. Vishwanatha, J. K., Chiang, Y., Kumble, K. D., Hollingsworth, M. A., and Pour, P. M. (1993) Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14, 2575-2579 (Pubitemid 24016599)
26. Chiang, Y., Rizzino, A., Sibenaller, Z. A., Wold, M. S., and Vishwanatha, J. K. (1999) Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol. Cell Biochem. 199, 139-147 (Pubitemid 29476152)
27. Kumble, K. D., Iversen, P. L., and Vishwanatha, J. K. (1992) The role of primer recognition proteins in DNA replication. Inhibition of cellular proliferation by antisense oligodeoxyribonucleotides. J. Cell Sci. 101, 35-41
28. Vishwanatha, J. K., Jindal, H. K., and Davis, R. G. (1992) The role of primer recognition proteins in DNA replication. Association with nuclear matrix in HeLa cells. J. Cell Sci. 101, 25-34
29. Vishwanatha, J. K., and Kumble, S. (1993) Involvement of annexin II in DNA replication. Evidence from cell-free extracts of Xenopus eggs. J. Cell Sci. 105, 533-540 (Pubitemid 23234172)
30. Zhang, J., Guo, B., Zhang, Y., Cao, J., and Chen, T. (2010) Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion. Saudi Med. J. 31, 374-381
31. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., and Thun, M. J. (2006) Cancer statistics, 2006. CA Cancer J. Clin. 56, 106-130
32. Brambilla, E., Travis, W. D., Colby, T. V., Corrin, B., and Shimosato, Y. (2001) The new World Health Organization classification of lung tumors. Eur. Respir. J. 18, 1059-1068 (Pubitemid 34092881)
33. Sun, S., Schiller, J. H., Spinola, M., and Minna, J. D. (2007) New molecularly targeted therapies for lung cancer. J. Clin. Invest. 117, 2740-2750 (Pubitemid 47529602)
34. Wang, T., Nelson, R. A., Bogardus, A., and Grannis, F. W., Jr. (2010) Five-year lung cancer survival. Which advanced stage nonsmall cell lung cancer patients attain long-term survival? Cancer 116, 1518-1525
35. Win, T., Sharples, L., Groves, A. M., Ritchie, A. J., Wells, F. C., and Laroche, C. M. (2008) Predicting survival in potentially curable lung cancer patients. Lung 186, 97-102
36. Feigenberg, S. J., Hanlon, A. L., Langer, C., Goldberg, M., Nicolaou, N., Millenson, M., Coia, L. R., Lanciano, R., and Movsas, B. (2007) A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. J. Thorac. Oncol. 2, 287-292 (Pubitemid 47181710)
37. Albain, K. S., Swann, R. S., Rusch, V. W., Turrisi, A. T., 3rd, Shepherd, F. A., Smith, C., Chen, Y., Livingston, R. B., Feins, R. H., Gandara, D. R., Fry, W. A., Darling, G., Johnson, D. H., Green, M. R., Miller, R. C., Ley, J., Sause, W. T., and Cox, J. D. (2009) Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer.Aphase III randomized controlled trial. Lancet 374, 379-386
38. Sato, M., Shames, D. S., Gazdar, A. F., and Minna, J. D. (2007) A translational view of the molecular pathogenesis of lung cancer. J. Thorac. Oncol. 2, 327-343 (Pubitemid 47181718)
39. Cole, S. P., Pinkoski, M. J., Bhardwaj, G., and Deeley, R. G. (1992) Elevated expression of annexin II (lipocortin II, p36) in a multidrug-resistant small cell lung cancer cell line. Br. J. Cancer 65, 498-502
40. Brichory, F. M., Misek, D. E., Yim, A. M., Krause, M. C., Giordano, T. J., Beer, D. G., and Hanash, S. M. (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 98, 9824-9829 (Pubitemid 32769388)
41. Langfort, R. (2010) [The new recommendation of the 7th edition of TNM classification for Lung Cancer in pathologic assesssment (pTNM)]. Pneumonol. Alergol. Pol. 78, 379-383
42. Tsai, C. C., Kai, J. I., Huang, W. C., Wang, C. Y., Wang, Y., Chen, C. L., Fang, Y. T., Lin, Y. S., Anderson, R., Chen, S. H., Tsao, C. W., and Lin, C. F. (2009) Glycogen synthase kinase-3β facilitates IFN-γ-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J. Immunol. 183, 856-864
43. Sasaki, K., Tsuno, N. H., Sunami, E., Tsurita, G., Kawai, K., Okaji, Y., Nishikawa, T., Shuno, Y., Hongo, K., Hiyoshi, M., Kaneko, M., Kitayama, J., Takahashi, K., and Nagawa, H. (2010) Chloroquine potentiates the anticancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer 10, 370-381
44. Jascur, T., Brickner, H., Salles-Passador, I., Barbier, V., El Khissiin, A., Smith, B., Fotedar, R., and Fotedar, A. (2005) Regulation of p21WAF1/CIP1 stability by WISp39, a Hsp90 binding TPR protein. Mol. Cell 17, 237-249 (Pubitemid 40138618)
45. Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A. (2003) DAVID. Database for annotation, visualization, and integrated discovery. Genome Biol. 4, P3
46. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
47. Warnes, G. R., Bolker, B., and Lumley, T. (2009) gplots: Various R programming tools for plotting data. R Package version 2.7.4
48. Shiozawa, Y., Havens, A. M., Jung, Y., Ziegler, A. M., Pedersen, E. A., Wang, J., Wang, J., Lu, G., Roodman, G. D., Loberg, R. D., Pienta, K. J., and Taichman, R. S. (2008) Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J. Cell Biochem. 105, 370-380
49. Taylor, W. R., and Stark, G. R. (2001) Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815 (Pubitemid 32458690)
50. Greenberg, A. K., Basu, S., Hu, J., Yie, T. A., Tchou-Wong, K. M., Rom, W. N., and Lee, T. C. (2002) Selective p38 activation in human non-small cell lung cancer. Am. J. Respir. Cell Mol. Biol. 26, 558-564 (Pubitemid 34315863)
51. Khatlani, T. S., Wislez, M., Sun, M., Srinivas, H., Iwanaga, K., Ma, L., Hanna, A. E., Liu, D., Girard, L., Kim, Y. H., Pollack, J. R., Minna, J. D., Wistuba, I. I., and Kurie, J. M. (2007) c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene 26, 2658-2666 (Pubitemid 46632007)
52. Hollander, M. C., Maier, C. R., Hobbs, E. A., Ashmore, A. R., Linnoila, R. I., and Dennis, P. A. (2011) Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene 30, 1812-1821
53. Schreiber, M., Kolbus, A., Piu, F., Szabowski, A.,Möhle-Steinlein, U., Tian, J., Karin, M., Angel, P., and Wagner, E. F. (1999) Control of cell cycle progression by c-Jun is p53-dependent. Genes Dev. 13, 607-619 (Pubitemid 29131884)
54. Stepniak, E., Ricci, R., Eferl, R., Sumara, G., Sumara, I., Rath, M., Hui, L., and Wagner, E. F. (2006) c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev. 20, 2306-2314
55. Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J. P., Rath, M., and Wagner, E. F. (2003) Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192 (Pubitemid 36144108)
56. Das, M., Jiang, F., Sluss, H. K., Zhang, C., Shokat, K. M., Flavell, R. A., and Davis, R. J. (2007) Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc. Natl. Acad. Sci. U.S.A. 104, 15759-15764 (Pubitemid 350035373)
57. Braden, A. R., Kafka, M. T., Cunningham, L., Jones, H., and Vishwanatha, J. K. (2009) Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J. Nanosci. Nanotechnol. 9, 2856-2865
58. Wang, Y. X., Lv, H., Li, Z. X., Li, C., and Wu, X. Y. (2012) Effect of shRNA-mediated down-regulation of annexin A2 on biological behavior of human lung adencarcinoma cells A549. Pathol. Oncol. Res. 18, 183-190
59. Wang, C. Y., Lin, Y. S., Su, W. C., Chen, C. L., and Lin, C. F. (2009) Glycogen synthase kinase-3 and Omi/HtrA2 induce Annexin A2 cleavage followed by cell cycle inhibition and apoptosis. Mol. Biol. Cell 20, 4153-4161
60. Fritsche, M., Haessler, C., and Brandner, G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-318 (Pubitemid 23073746)
61. Shang, L., Zhou, H., Xia, Y., Wang, H., Gao, G., Chen, B., Liu, Q., Shao, C., and Gong, Y. (2009) Serum withdrawal up-regulates human SIRT1 gene expression in a p53-dependent manner. J. Cell Mol. Med. 13, 4176-4184
62. Huang, Y., Jin, Y., Yan, C. H., Yu, Y., Bai, J., Chen, F., Zhao, Y. Z., and Fu, S. B. (2008) Involvement of Annexin A2 in p53-induced apoptosis in lung cancer. Mol. Cell Biochem. 309, 117-123
63. Kruse, J. P., and Gu, W. (2009) Modes of p53 regulation. Cell 137, 609-622
64. Hollstein, M., and Hainaut, P. (2010) Massively regulated genes. The example of TP53. J. Pathol. 220, 164-173
65. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597
66. Ohtani-Fujita, N., Minami, S., Mimaki, S., Dao, S., and Sakai, T. (1998) p53-Independent activation of the gadd45 promoter by Δ12-prostaglandin J2. Biochem. Biophys. Res. Commun. 251, 648-652 (Pubitemid 28505077)
67. Pedeux, R., Lefort, K., Cuenin, C., Cortes, U., Kellner, K., Doré, J. F., and Nakazawa, H. (2002) Specific induction of gadd45 in human melanocytes and melanoma cells after UVB irradiation. Int. J. Cancer 98, 811-816 (Pubitemid 34286674)
68. Ishida, T., Suzuki, T., Hirashima, S., Mizutani, K., Yoshida, A., Ando, I., Ikeda, S., Adachi, T., and Hashimoto, H. (2006) Benzimidazole inhibitors of hepatitis C virus NS5B polymerase. Identification of 2-[(4-diarylmethoxy) phenyl]-benzimidazole. Bioorg. Med. Chem. Lett. 16, 1859-1863 (Pubitemid 43267365)
69. Treier, M., Staszewski, L. M., and Bohmann, D. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain. Cell 78, 787-798 (Pubitemid 24294454)
70. Wagner, E. F., and Nebreda, A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
71. Huang, P., Han, J., and Hui, L. (2010) MAPK signaling in inflammation-associated cancer development. Protein Cell 1, 218-226
72. Inanami, O., Ohta, T., Ito, S., and Kuwabara, M. (1999) Elevation of intracellular calcium ions is essential for the H2O2-induced activation of SAPK/JNK but not for that of p38 and ERK in Chinese hamster V79 cells. Antioxid. Redox Signal. 1, 501-508 (Pubitemid 129628312)
73. Liu, S. L., Lin, X., Shi, D. Y., Cheng, J., Wu, C. Q., and Zhang, Y. D. (2002) Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3K/PKB and JNK signaling pathways. Arch. Biochem. Biophys. 406, 173-182 (Pubitemid 35216343)
74. Matsukawa, J., Matsuzawa, A., Takeda, K., and Ichijo, H. (2004) The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. 136, 261-265 (Pubitemid 39545783)
75. Tanaka, T., Akatsuka, S., Ozeki, M., Shirase, T., Hiai, H., and Toyokuni, S. (2004) Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 23, 3980-3989 (Pubitemid 38747926)
76. Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R., and Chandel, N. S. (2010) Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. U.S.A. 107, 8788-8793
77. Frank, G. D., Motley, E. D., Inagami, T., and Eguchi, S. (2000) PYK2/CAKßrepresents a redox-sensitive tyrosine kinase in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 270, 761-765 (Pubitemid 30444779)
78. Zhang, S., Qiu, X., Gu, Y., and Wang, E. (2008) Up-regulation of prolinerich tyrosine kinase 2 in non-small cell lung cancer. Lung Cancer 62, 295-301
79. Tokiwa, G., Dikic, I., Lev, S., and Schlessinger, J. (1996) Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science 273, 792-794 (Pubitemid 26271523)
80. Halfter, U. M., Derbyshire, Z. E., and Vaillancourt, R. R. (2005) Interferon-γ-dependent tyrosine phosphorylation of MEKK4 via Pyk2 is regulated by annexin II and SHP2 in keratinocytes. Biochem. J. 388, 17-28 (Pubitemid 40732928)
81. Minden, A., Lin, A., Claret, F. X., Abo, A., and Karin, M. (1995) Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81, 1147-1157
82. Teramoto, H., Coso, O. A., Miyata, H., Igishi, T., Miki, T., and Gutkind, J. S. (1996) Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family. J. Biol. Chem. 271, 27225-27228 (Pubitemid 26367270)
83. Brumby, A. M., Goulding, K. R., Schlosser, T., Loi, S., Galea, R., Khoo, P., Bolden, J. E., Aigaki, T., Humbert, P. O., and Richardson, H. E. (2011) Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster. A RhoGEF/Rho-family/JNK pathway is a central driver of tumorigenesis. Genetics 188, 105-125
84. 2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res. 60, 400-408
85. Hansen, M. D., Ehrlich, J. S., and Nelson, W. J. (2002) Molecular mechanism for orienting membrane and actin dynamics to nascent cell-cell contacts in epithelial cells. J. Biol. Chem. 277, 45371-45376 (Pubitemid 36159145)
86. He, K. L., Deora, A. B., Xiong, H., Ling, Q., Weksler, B. B., Niesvizky, R., and Hajjar, K. A. (2008) Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J. Biol. Chem. 283, 19192-19200
87. Petersson, S., Shubbar, E., Enerbäck, L., and Enerbäck, C. (2009) Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Melanoma Res. 19, 215-225
88. Yang, X., Popescu, N. C., and Zimonjic, D. B. (2011) DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. Cancer Res. 71, 2916-2925
89. König, J., Prenen, J., Nilius, B., and Gerke, V. (1998) The annexin II-p11 complex is involved in regulated exocytosis in bovine pulmonary artery endothelial cells. J. Biol. Chem. 273, 19679-19684 (Pubitemid 28367025)